Jones, David

Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial

Jones, D., Carbone, M., Invernizzi, P., Little, N., Nevens, F., Swain, M. G., Wiesel, P., & Levy, C. (2023) · Hepatology Communications

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 37

Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom

Rice, S., Albani, V., Minos, D., Fattakhova, G., Mells, G. F., Carbone, M., Flack, S., Varvaropoulou, N., Badrock, J., Spicer, A., et al. (2021) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityHealth Systems, Economic Evaluations, Quality of Life

Cited by 32

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

Martinez-Gili, L., Pechlivanis, A., McDonald, J. A. K., Begum, S., Badrock, J., Dyson, J. K., Jones, R., Hirschfield, G., Ryder, S. D., Sandford, R., et al. (2023) · Gut Microbes

Liver Diseases and ImmunityGut microbiota and health

Cited by 32

Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery

Abbas, N., Smith, R., Flack, S., Bains, V., Aspinall, R. J., Jones, R. L., Burke, L., Thorburn, D., Heneghan, M., Yeoman, A., et al. (2024) · JHEP Reports

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 31

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

Jones, D. E. J., Wetten, A., Barron-Millar, B., Ogle, L., Mells, G., Flack, S., Sandford, R., Kirby, J., Palmer, J., Brotherston, S., et al. (2022) · eBioMedicine

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 22

Primary biliary cirrhosis is associated with falls and significant fall related injury

Frith, J., Kerr, S., Robinson, L., Elliott, C., Ghazala, C., Wilton, K., Pairman, J., Jones, D. E. J., & Newton, J. L. (2010) · QJM

Balance, Gait, and Falls PreventionLiver Diseases and Immunity

Cited by 21

Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results

Levy, C., Trivedi, P. J., Kowdley, K. V., Gordon, S. C., Bowlus, C. L., Londoño, M. C., Hirschfield, G. M., Gulamhusein, A., Lawitz, E. J., Vierling, J. M., et al. (2026) · American Journal of Gastroenterology

Liver Diseases and ImmunityPeroxisome Proliferator-Activated Receptors

Cited by 20

Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice

Gee, L. M. V., Barron-Millar, B., Leslie, J., Richardson, C., Zaki, M. Y. W., Luli, S., Burgoyne, R. A., Cameron, R. I. T., Smith, G. R., Brain, J. G., et al. (2023) · The American Journal of Pathology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 18

P1152: a comparative study of pruritus in PBC cohorts from UK, USA and Italy

Hegade, V. S., Mells, G. F., Lammert, C., Juran, B., Lleo, A., Carbone, M., Lazaridis, K., Invernizzi, P., Kendrick, S., Sandford, R., et al. (2015) · Journal of Hepatology

Liver Diseases and ImmunityDermatology and Skin Diseases

Cited by 15